The healing of articular cartilage is limited after a defect caused by trauma or osteoarthritis. Higher percentages of fibrous cartilage instead of hyaline cartilage are generated during the repair process of a full-thickness defect, which leads to a repair tissue that is biomechanically less resistant. Importantly, cells such as chondroblasts and chondrocytes in the repair tissue are produced by mesenchymal stem cells (MSCs) moving from the marrow. [1, 2] This process, also known as neochondrogenesis, is one of the most studied areas in recent years. Studies on skeleton metabolism have led to the identification of a number of factors involved in the cartilage formation by causing the differentiation of MSCs into chondrocytes. [1, 2] Growth factors such as recombinant human bone morphogenetic protein 2 (rhBMP-2), insulin-like growth factor-1 (IGF-1) and basic fibroblast growth factor (bFGF) play a role in the repair of full-thickness defect by increasing the ratio of collagen type 2 which leads to the increased mechanical strength of cartilage. [3] [4] [5] Studies have shown that transforming growth factor-beta (TGF-b) promotes cartilage differentiation of bone marrow MSCs in vitro and in vivo. [6] Platelet-derived growth factor (PDGF) can exist as homo-or heterodimer. Platelet-derived growth factor is a significant mitogenic and chemotactic growth factor for cells of mesenchymal origin such as chondrocytes and MSCs. Reports have shown that PDGF increases the proliferation and proteoglycan production of resting zone chondrocytes and stimulate meniscal cell proliferation and migration. [7, 8] Only a few studies have focused on the role of PDGF on the repair of full-thickness defect in articular cartilage in vivo. However, to our knowledge, there is no study on the efficacy of collagen sponge impregnated with PDGF in the repair of full-thickness defect. Therefore, in this study, we aimed to investigate the potential use and histological effects of the local administration of PDGF in the repair of full-thickness osteochondral defects in articular cartilage in an animal model.
MATERIALS AND METHODS

This study was conducted at Harran University Faculty of Medicine between March 2006 and June 2006 and included 24 adolescent 18-week-old
New Zealand white rabbits with an average weight of 2500 g (range, 1600 g to 3200 g). The rabbits were divided into three groups (n=8) including the control group (group A) and two experimental groups (groups B and C). The ethic regulations have been The right knee joint was approached through a 3 cm medial parapatellar incision under sterile conditions. The patella was dislocated laterally by medial arthrotomy to expose the articular surface. A full-thickness defect (3.5 mm in diameter, 4 mm in depth) was generated in the medial femoral condyle in the weight-bearing area, using a hand perforator with a 3.5 mm diameter drill-bit, as previously described. [9] The joint capsule was closed by precise suturing. In group A, the defect was left empty. In group B, the defect was filled with a collagen sponge. In group C, the defect was filled with collagen sponge impregnated with 62.5 ng of human PDGF (Sigma-Aldrich ® Catalog no: P-8147, St. Louis, MO, USA). After surgery, all animals were allowed to move freely in their cages. All rabbits were sacrificed at 12 weeks after surgery by intravenous injection of 7.5% potassium chloride.
Right knee femoral condyles were obtained from all sacrificed animals. Defects were photographed and investigated macroscopically. Samples were placed into 10% buffered formalin, decalcified and paraffinized. Sections of 4 µm were cut and stained with hematoxylin-eosin. Cartilage matrix was stained with toluidine blue (TB). Periphery of the defect was compared with the normal tissue. A collagen type 2 specific antibody (Ab-2, Neomarkers ® , Fremont, CA, USA) was used for immunostaining.
The modified histological scale from Sellers et al. [4] was used for scoring. [4] The scoring system consists of eight different categories (Table I) with a total score ranging from 0 points (normal cartilage) to 31 points (no repair tissue). The eight categories used for evaluation are as follows: [4] Filling of defect relative to surface of normal adjacent cartilage; integration of repair tissue with surrounding articular cartilage; 
Statistical analysis
All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 11.0 for Windows (SPSS Inc., Chicago, IL, USA) software. The histopathological differences were analyzed by Kruskal-Wallis test. Mann-Whitney U test was used to identify the differences between various treatment groups. A p value of ≤0.05 was considered statistically significant.
RESULTS
Macroscopic properties of the defect were examined in all groups. At 12 weeks, the color of repair tissue in group A was between white and purple and had an irregular surface. In contrast, the color and structure of the repair cartilage were similar to the adjacent normal cartilage in groups B and C.
Defects were mostly filled with cartilage areas and there was a good continuity with normal cartilage. The color of repair tissue was cloudy white. The surface of the repair tissue in group C was smoother and more regular compared to groups A and B.
Sections taken from the center of the defect were used for the evaluation (Figure 1 ). Histological evaluations from the center of the defect revealed that most of the categories were significantly different between group A and groups B and C in all categories except categories 4 and 5 (Table I) . Categories 1, 7 and 8 were significantly different between groups A and B, while no significant difference was found for categories 2, 3, 4, 5 and 6 ( Table I) . Groups A and C were significantly different for most categories except for categories 4 and 5 (Table I) . Groups B and C were also significantly different for most categories except for categories 1 and 4 (Table I ). Toluidine blue staining was used to stain cartilage matrix. There was little matrix staining in the repair tissue compared to adjacent normal cartilage in group A. In group B, matrix staining was at the medium level. In group C, the matrix staining in the repair tissue was close to the level in the adjacent normal cartilage (Figure 2a , b and c, respectively). Collagen type 2 staining was not present in group A whereas a weak to medium staining was found in group B and a medium to strong staining was present in group C. There was intra-cytoplasmic staining in group C as well (Figure 2d, e and f, respectively) .
DISCUSSION
This study showed that the local administration of 62.5 ng of PDGF in a collagen sponge led to macroscopic and histological improvement in full-thickness osteochondral defect. In group C (PDGF-treated animals), total histological score was significantly lower than group A (control animals) (total score: group A, 23.00±2.37; group C, 11.00±1.67; p<0.001). Sellers et al. [4] showed that total histological score was 8.6±4.1 and 9±2.71 in rhBMP-2 treated experimental groups at six months and in one year, respectively. They also showed that total histological score was 14.30±5.58 in control group in one year (p<0.05). [4, 10] Tuncel et al. [5] demonstrated that the IGF-1-treated group had a mean histological score of 5.5 (range, 4 to 9) whereas the mean score of the control group was 12 (range, 8 to 17) at 12 weeks (p<0.05). In another study, bFGF induced cartilage healing with a histological score of 3 in the treated group compared to a histological score of 6 in the control group at the end of 12 weeks. [11] In these studies, growth factors other than PDGF have been studied and shown to be efficient. In our study, PDGF has shown a comparable level of efficacy at 12 weeks.
In our study, collagen type 2 staining, which is known to increase the resistance of articular cartilage, was intense in repaired defects of group C, whereas a medium level of immunostaining for collagen type 2 was found in group B. Tuncel et al. [5] showed increased collagen type 2 immunostaining in rabbit joints treated locally with IGF-1 at 12 weeks after defect formation. In their study with bFGF, Fujimato et al. [3] showed immunostaining of collagen type 2 both in the surface and deeper regions of the repaired tissue in the control group at one year after the defect formation.
Platelet-derived growth factor injected into the articular joint of growing rats caused an early, transitory induction of the osteogenic activity in the zone between cartilage and red bone marrow. [12] Several studies have focused on the molecular and cellular mechanisms of the effect of PDGF on chondrocyte cells. Schmidt et al. [8] demonstrated that PDGF two B chains (PDGF-BB) induced chondrocyte proliferation at dose between 4.7 and 300 ng. In our study, a PDGF A and B chains (PDGF-AB) heterodimer was used. A mixture of TGF-b1, bFGF and PDGF supplementation allowed the increase of the chondrogenic potential of costochondral cells in vitro, which was demonstrated by enhanced type 2 collagen ratio and compressive properties. [13] Furthermore, PDGF can also regulate chondrocyte proliferation through extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. [14] These studies give an idea about molecular networks in which PDGF has a role and suggest a molecular mechanism of action for the role of PDGF in the repair of cartilage in our animal model.
Yokoyama et al. [15] showed that platelet-activated serum had a positive impact on the repair of articular cartilage in rabbits subjected to anterior cruciate ligament transection. They demonstrated that platelet-activated serum had high levels of vascular endothelial growth factor (VEGF), PDGF-BB and TGF-b. In another study, an osteochondral defect (size of 10x6 mm) was created in femoral condyles of pigs by Betsch et al. [16] Bone marrow aspiration concentrate and platelet rich plasma (PRP) were found to cause a significant improvement in the defect repair histologically. Platelet rich plasma had high levels of growth factors such as bone morphogenetic protein 2 (BMP-2), BMP-7, VEGF, TGF-b1 and PDGF. [16] In these studies, growth-factor enriched materials such as platelet activated serum or PRP were used and a therapeutic effect was shown. Although one of the factors enriched was PDGF, the effect was most probably due to the combination of these factors. On the other hand, our study focused on the use of PDGF alone in a collagen sponge as a scaffold. Therefore, our study is different from these studies as it shows individual activity of PDGF in a collagen sponge scaffold. [17] In a clinical study, the PDGF concentration was significantly higher in anterior cruciate ligament reconstructed knee group than in the meniscectomy group and correlated with a higher healing rate of the meniscus. Therefore, it has been suggested that PDGF may have a critical role in the healing response of meniscus suture. [18] In a clinical study focusing on PDGF, five patients with an isolated osteochondral defect were treated with recombinant human PDGF in a matrix of tricalcium phosphate after arthroscopic debridement. The mean weightbearing visual analog scale pain score and the mean osteoarthritis scale functional score improved. Bone healing was observed by computed tomography. [19] This study puts emphasis on the role of PDGF alone in the repair of osteochondral defects in patients. Our study is different from this study as it has been performed in an animal model using a different scaffold, collagen sponge. Moreover, repair tissue was investigated histologically in our study, which would not be feasible in a study with patients in the clinic.
A limitation of our study was having a single time point, which was 12 weeks. Having multiple time points with an increased number of animals would make our study stronger. A 12-week period was considered as the minimum time period for the repair of cartilage. As a matter of fact, we observed the formation of hyaline-like cartilage and collagen type 2 in this time period.
In conclusion, to the best of our knowledge, only a few studies have focused on the use of PDGF for the repair of articular cartilage in animal models. Our study demonstrates the potential use of locally applied PDGF in a collagen sponge for full-thickness osteochondral defects. The dose of PDGF may be standardized in experimental models and PDGF may become an appropriate treatment for osteochondral defects in clinical setting.
